| Q35953397 | "Missing" inhibitors of calcification: general aspects and implications in renal failure |
| Q24291557 | Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins |
| Q39071314 | Arterial Calcification in Diabetes Mellitus: Preclinical Models and Translational Implications. |
| Q27024623 | Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease |
| Q34277172 | BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxia |
| Q36520158 | BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice |
| Q58042952 | Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells |
| Q28569097 | Bone morphogenetic protein 4 enhances canonical transient receptor potential expression, store-operated Ca2+ entry, and basal [Ca2+]i in rat distal pulmonary arterial smooth muscle cells |
| Q34567420 | Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy. |
| Q24655399 | Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study |
| Q73376498 | Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells |
| Q37211143 | CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas |
| Q34586794 | Calcifying vascular smooth muscle cells and osteoblasts: independent cell types exhibiting extracellular matrix and biomineralization-related mimicries. |
| Q61927929 | Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease |
| Q34726861 | Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis |
| Q35534610 | Combinatorial roles for BMPs and Endothelin 1 in patterning the dorsal-ventral axis of the craniofacial skeleton |
| Q58703705 | Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension |
| Q36119870 | Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors |
| Q36961302 | Endothelial Bmp4 is induced during arterial remodeling: effects on smooth muscle cell migration and proliferation |
| Q35550184 | From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family |
| Q39640769 | Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension |
| Q33352008 | Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel |
| Q80216002 | Gremlin promotes vascular smooth muscle cell proliferation and migration |
| Q33761721 | Heart failure and pulmonary hypertension |
| Q28361811 | Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension |
| Q50053071 | LncRNA MALAT1 regulates smooth muscle cell phenotype switch via activation of autophagy |
| Q35127451 | Long Term Effect of High Glucose and Phosphate Levels on the OPG/RANK/RANKL/TRAIL System in the Progression of Vascular Calcification in rat Aortic Smooth Muscle Cells |
| Q42437262 | Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth. |
| Q92502107 | Medial artery calcification increases neointimal hyperplasia after balloon injury |
| Q24679149 | New insights into the pathogenesis and treatment of primary pulmonary hypertension |
| Q37220566 | Non-crystalline and crystalline rheumatic disorders in chronic kidney disease |
| Q73370839 | Primary pulmonary hypertension |
| Q37359962 | TGF-beta signaling in vascular biology and dysfunction |
| Q37976673 | TGFβ signaling and cardiovascular diseases |
| Q26783734 | Targeting BMP signalling in cardiovascular disease and anaemia |
| Q92923287 | The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases |
| Q87829005 | The TGFβ superfamily in cardiac dysfunction |
| Q38172438 | The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing |
| Q36677622 | The mechanism of phosphorus as a cardiovascular risk factor in CKD |
| Q37446201 | The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature |
| Q33646711 | Vascular Calcification: Current Genetics Underlying This Complex Phenomenon |